Primary debulking surgery vs neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A propensity-matched analysis
American Journal of Clinical Oncology Mar 03, 2018
Siesto G, et al. - Patients undergoing primary debulking surgery (PDS) versus neoadjuvant chemotherapy (NACT) plus interval debulking surgery (IDS) for advanced epithelial ovarian cancer (EOC) were compared in terms of surgical and survival outcomes. Comparable progression-free and overall survival were reported among patients who underwent PDS or treated with NACT plus IDS for advanced EOC.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
